Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06072755 · ClinicalTrials.gov registry record
Tissue Oxygen Use With Combined Arteriovenous Noninvasive Oximetry
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 20
- Enrollment target
NCT06072755: Completed study, sponsored by University of Wisconsin, Madison.
NCT06072755 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06072755 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The goal of this observational study is to find out if researchers can measure oxygen consumption in the body without having to draw blood from lines in arteries and central veins. Participants will undergo measurements of arterial blood oxygen saturation using both finger and neck pulse oximeters.
Primary Outcome
Difference in the standard deviation of the arteriovenous saturation difference comparing noninvasive photoplethysmography to invasive blood sampling and oximetry
Interventions
- DEVICE Finger pulse oximetry probe
- DEVICE Transreflectance oximetry probe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-01-11 |
| Est. Completion | 2024-07-25 |
What the finished NCT06072755 record still lists
NCT06072755 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Finger pulse oximetry probe is the first listed.
NCT06072755 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06072755 about?
NCT06072755 is a clinical study titled "Tissue Oxygen Use With Combined Arteriovenous Noninvasive Oximetry". The goal of this observational study is to find out if researchers can measure oxygen consumption in the body without having to draw blood from lines in arteries and central veins. Participants will undergo measurements of arterial blood oxygen saturation using both finger and neck pulse oximeters.
What is the current status of trial NCT06072755?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2024-01-11. Estimated completion is 2024-07-25.
What interventions are being tested in trial NCT06072755?
The interventions under investigation include: Finger pulse oximetry probe (DEVICE), Transreflectance oximetry probe (DEVICE).
Who is sponsoring clinical trial NCT06072755?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI